Newsroom

Get the latest news and press releases from CathWorks, plus upcoming events and useful information for physicians, patients, and media.

Filter

Press Release

CathWorks Adds Vice President of Global Marketing to Leadership Team

Feb 25, 2019

CathWorks announced that Ramin Mousavi has joined as Vice President of Global Marketing & Strategy to take responsibility

Read More arrow_forward

Press Release

CathWorks Announces Completion Of $30 Million Financing

Feb 04, 2019

CathWorks announced the completion of a $30 million Series C financing round led by Deerfield Management.

Read More arrow_forward

Press Release

CathWorks Names Paul Kapsner as Vice President of Sales

Dec 27, 2018

CathWorks announced that Paul Kapsner has been named as Global Vice President of Sales.

Read More arrow_forward

Press Release

CathWorks FFRangio™ System Receives U.S. FDA Clearance

Dec 20, 2018

CathWorks announced today that its FFRangio™ System received United States Food & Drug Administration (FDA) 510(k) clearance.

Read More arrow_forward

Press Release

CathWorks FFRangio™ Trial Meets Primary Enpoint and Exceeds Performance Goals

Sep 24, 2018

The journal Circulation published results from the CathWorks FFRangio™ FAST-FFR clinical trial in an article titled Accuracy of Fractional Flow Reserve Derived From Coronary Angiography.

Read More arrow_forward

Press Release

CathWorks FFRangio™ System Clinical Review Featured in TCT 2018 Program

Sep 12, 2018

The CathWorks FFRangio™ System will be featured in a TCT Lunch Presentation Theater Program held during the 2018 TCT (Transcatheter Cardiovascular Therapeutics) annual meeting in San Diego.

Read More arrow_forward

Press Release

FAST-FFR Pivotal Trial Added To TCT 2018 Late-Breaking Clinical Trial Program

Aug 29, 2018

CathWorks announced that the FAST-FFR pivotal trial has been added to the late-breaking clinical science program during the 2018 TCT (Transcatheter Cardiovascular Therapeutics) annual meeting in San Diego.

Read More arrow_forward

Press Release

CathWorks FFRangio™ System files FDA 510(k) Submission

Aug 22, 2018

CathWorks announced that it has submitted its CathWorks FFRangio™ System to the United States Food & Drug Administration (FDA) for review and 510(k) market clearance.

Read More arrow_forward

Learn how the CathWorks FFRangio® System can impact your practice.

    *Required

    expand_lessBack to top of page

    We use cookies to enhance your experience. By continuing to visit this site, you agree to our use of cookies. Terms and Conditions

    Accept